Author: Ken Dropiewski

NorthShore University HealthSystem, Carnegie Mellon University and PhysIQ Launch Comprehensive Study of New Technology to Monitor At-Risk Cardiac and Surgical Patients

CHICAGO–(BUSINESS WIRE)–NorthShore University HealthSystem (NorthShore), Carnegie Mellon University, and physIQ are collaborating on a multi-phase pilot project using the pinpointIQ™ solution to manage patients with heart failure and patients undergoing ileostomy. These patient populations historically have significant clinical risks when transitioning from the hospital to home. Using this solution, NorthShore will be able […]

FDA Issues Emergency Use Authorization for Impella Heart Pumps to Provide Unloading Therapy to COVID-19 Patients

DANVERS, Mass.–(BUSINESS WIRE)–The United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for left-sided Impella heart pumps to provide left ventricular unloading and support to COVID-19 patients who are undergoing ECMO treatment and develop pulmonary edema or myocarditis. Impella is manufactured by Abiomed (NASDAQ: ABMD). COVID-19 causes widespread inflammation which can […]

Abbott Announces Start of Study to Evaluate New Device to Treat Recurrent Atrial Fibrillation

– Recurrent irregular heartbeat–also known as atrial fibrillation–impacts more than 16 million people globally – Trial supports Abbott’s focus on being the best partner for electrophysiologists treating people living with atrial fibrillation ABBOTT PARK, Ill., Aug. 4, 2020 /PRNewswire/ — Abbott (NYSE: ABT) today announced first enrollments in the TactiFlex PAF IDE study to […]

JanOne Changes Internal Drug Candidate Name from TV1001SR to JAN101

LAS VEGAS, Aug. 4, 2020 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, announces a internal name change for its current drug candidate from TV1001SR to JAN101, soon to enter Phase 2b clinical trials as a potential treatment Peripheral […]

Cerus Endovascular and Balt Enter Strategic Distribution Agreement for Innovative Neurovascular Devices to Treat a Range of Intracranial Aneurysms

Balt to Commercialize Cerus Endovascular’s Contour Neurovascular System™ and Neqstent Coil Assisted Flow Diverter in Germany FREMONT, Calif. and OXFORD, United Kingdom and MONTMORENCY, France, Aug. 4, 2020 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company and AB Medica Deutschland Verwaltungs GmbH, a wholly owned subsidiary of Balt, today announced that they have entered into […]

BioSig Installs PURE EP(tm) System at Massachusetts General Hospital

Patient cases are set to commence in August Westport, CT, Aug. 04, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac […]

Amarin Announces Plans to Maximize Blockbuster Potential of VASCEPA® (icosapent ethyl) in Europe

Amarin to Build Dedicated Organization to Retain Substantial Value of One of the Most Anticipated Cardiovascular Drug Products in Decades Veteran Cardiovascular Commercial Executive Hired to Lead Focused Launch DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), today announced the company’s plans to undertake […]

Amarin Reports Second Quarter 2020 Financial Results and Provides Update on Operations

Total Revenue Increased 34% in Second Quarter 2020 Compared to Second Quarter 2019 Despite COVID-19 Headwinds Multiple Upcoming Milestones Regarding VASCEPA® Opportunity in United States and Internationally Management to Host Conference Call Today at 7:30 a.m. ET DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), today […]

Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics

COVID-19 Preclinical Work Continues CALGARY, Alberta, Aug. 04, 2020 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) is pleased to announce today the recent publication of an article titled: “Epigenetic modulation by apabetalone counters cytokine driven acute phase response in vitro, in mice and in patients with cardiovascular disease”, in […]

iRhythm Technologies Comments on the Centers for Medicare and Medicaid Services 2021 Proposed Physician Fee Schedule

SAN FRANCISCO, Aug. 04, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, commented on the recently released Centers for Medicare and Medicaid Services (“CMS”) Calendar Year 2021 Medicare Physician Fee Schedule Proposed Rule (the “Proposed Rule”). […]